Dr. Pecora on HPV Cervical Cancer Findings

Andrew L. Pecora, MD, FACP, CPE
Published: Wednesday, May 18, 2011

Andrew L. Pecora, MD, FACP, CPE the Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center on findings from the HPV Cervical Cancer Study.

Dr. Pecora says one of the first exciting things for women who are afflicted with HPV is a study that shows these women can increase the intervals between the times they are having follow up tests and don't need to rely on pap smears as much. The data from the study shows that an HPV test is sufficient to give a woman an idea of what her risks are for the subsequent development of cervical cancer.
SELECTED
LANGUAGE
Andrew L. Pecora, MD, FACP, CPE the Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center on findings from the HPV Cervical Cancer Study.

Dr. Pecora says one of the first exciting things for women who are afflicted with HPV is a study that shows these women can increase the intervals between the times they are having follow up tests and don't need to rely on pap smears as much. The data from the study shows that an HPV test is sufficient to give a woman an idea of what her risks are for the subsequent development of cervical cancer.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication
x